Compare ANIX & HYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANIX | HYNE |
|---|---|---|
| Founded | 1982 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.0M | 112.1M |
| IPO Year | 1987 | N/A |
| Metric | ANIX | HYNE |
|---|---|---|
| Price | $3.18 | $14.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 256.6K | 87.4K |
| Earning Date | 01-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $13,191,325.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.86 |
| 52 Week Low | $2.12 | $13.35 |
| 52 Week High | $5.46 | $14.60 |
| Indicator | ANIX | HYNE |
|---|---|---|
| Relative Strength Index (RSI) | 40.61 | N/A |
| Support Level | $3.07 | N/A |
| Resistance Level | $3.36 | N/A |
| Average True Range (ATR) | 0.17 | 0.00 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 23.08 | 0.00 |
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
Hoyne Bancorp Inc is a holding company that conducts business mainly through its subsidiaries. It is a savings institution focused on serving customers' banking needs in the market area. The group offers Personal and Business banking services.